HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.

AbstractOBJECTIVES:
To determine patterns of hypometabolism on fluorodeoxyglucose F18 positron emission tomography (FDG-PET) in patients with progressive apraxia of speech (PAS) and primary progressive aphasia (PPA) variants and to use these patterns to further refine current classification.
DESIGN:
We identified all patients who had FDG-PET and PAS or PPA who were evaluated by an expert speech-language pathologist. Patterns of hypometabolism were independently classified by 2 raters blinded to clinical data. Three speech-language pathologists reclassified all patients into 1 of 7 operationally defined categories of PAS and PPA blinded to FDG-PET data.
SETTING:
Tertiary care medical center.
PATIENTS:
Twenty-four patients with PAS or PPA and FDG-PET.
MAIN OUTCOME MEASURE:
Fluorodeoxyglucose F18 PET hypometabolic pattern.
RESULTS:
Of the 24 patients in the study, 9 had nonfluent speech output; 14, fluent speech; and 1 was unclassifiable. Twenty-one patients showed FDG hypometabolism; the remaining 3 did not. Among the patients showing hypometabolism, 8 had a prerolandic pattern of which 7 had nonfluent speech including progressive nonfluent aphasia (n = 3), PAS (n = 1), and mixed nonfluent aphasia/apraxia of speech (n = 3); the other patient had PPA unclassifiable. The remaining 13 had a postrolandic pattern, all with fluent speech (P < .001), including logopenic progressive aphasia (n = 6), progressive fluent aphasia (n = 6), and semantic dementia (n = 1). Patterns of hypometabolism differed between the nonfluent variants and between the fluent variants, including progressive fluent aphasia.
CONCLUSION:
Patterns of FDG-PET hypometabolism support the clinical categorizations of fluency, the distinction of apraxia of speech from progressive nonfluent aphasia, and the designation of a progressive fluent aphasia category.
AuthorsKeith A Josephs, Joseph R Duffy, Tepanta R Fossett, Edythe A Strand, Daniel O Claassen, Jennifer L Whitwell, Patrick J Peller
JournalArchives of neurology (Arch Neurol) Vol. 67 Issue 5 Pg. 596-605 (May 2010) ISSN: 1538-3687 [Electronic] United States
PMID20457960 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Fluorodeoxyglucose F18
Topics
  • Aged
  • Aged, 80 and over
  • Aphasia, Primary Progressive (diagnostic imaging, metabolism, physiopathology)
  • Apraxias (diagnostic imaging, metabolism, physiopathology)
  • Brain (diagnostic imaging, metabolism, physiopathology)
  • Brain Mapping
  • Cohort Studies
  • Diagnosis, Differential
  • Energy Metabolism (physiology)
  • Female
  • Fluorodeoxyglucose F18
  • Functional Laterality (physiology)
  • Humans
  • Language Tests
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: